1/1

Export Ready

Ponatinib Tablets Ponaxen 15mg

Name: Ponatinib Tablets Ponaxen 15mg
SKU: 8495629
Price: 187.04 USD
Availability: InStock

Sold by BALAJI PHARMA · Retailer, Brand Owner, Distributor, Exporter, Importer, Wholesaler · Bengaluru, Karnataka, India

Price

₹ 187.04 /Bottle

In stock

Inclusive of all taxes

Minimum order: 1 Bottle

Export Snapshot

MOQ

1 Bottle

Lead time

On request

Packaging

Standard export packaging

Shelf life / longevity

As per product specification

HSN Code

On request

Origin

India

Port of dispatch

On request

Export markets served

Global markets

Values shown are for BALAJI PHARMA.

Suitable for

Importers · Distributors · Wholesalers

Bengaluru Dispatch on request Verified seller

BALAJI PHARMA

Retailer, Brand Owner, Distributor, Exporter, Importer, Wholesaler · Bengaluru, Karnataka, India

Registered address: Bengaluru, India. Industry: Healthcare, Medical Supplies & Pharmaceuticals > Health Care Products.

View profile All products

Established

Not shared

Employees

–

GST

29AQTPJ8785C1Z2

IEC code

Not shared

Export markets

Global markets

GlobalLinker Member Since

Aug 2019

Turnover

$250,000 - $1 MM

Incorporation Type

On request

Certifications & Awards

IMPORT EXPORT LICENSE ISSUED BY GOVERMENT OF INDIA GST ISSUED BY GOVERNMENT DRUG LICENSE ISSUED BY HEALTH AUTHORITY GOVERMENT

Product details

What are the specifications of this product?

Overview

Ponatinib Tablets Ponaxen 15mg are prescribed for treating specific leukemias, such as CML and ALL. As a tyrosine kinase inhibitor, Ponatinib targets proteins that aid cancer cell growth. Patients must follow their doctor's dosage instructions and monitor for side effects. Manufactured with high-quality standards, Ponaxen offers an effective approach to leukemia treatment.

Product Description

Ponatinib Tablets Ponaxen 15mg contain Ponatinib, a tyrosine kinase inhibitor used in the treatment of certain types of leukemia, including chronic myeloid leukemia (CML) and acute lymphoblastic leukemia (ALL). Ponatinib works by blocking specific proteins that promote the growth of cancer cells. Each bottle contains a specific number of tablets, with dosages determined by a healthcare provider based on individual patient needs. Patients should adhere to prescribed dosages and report any side effects to their doctor immediately. Ponaxen is manufactured under stringent quality standards to ensure its efficacy and safety.

Description provided by BALAJI PHARMA.

Specifications

Drug Class	Tyrosine Kinase Inhibitor (TKI)
Chemical Name	Ponatinib
Strength	15 mg
Dosage Form	Tablet
Route of Administration	Oral
Therapeutic Uses	Treatment of CML and Philadelphia chromosome-positive ALL
Storage Conditions	Store in a cool, dry place away from direct sunlight
Shelf Life	As per manufacturer’s label
Prescription Requirement	Prescription Only Medicine (POM)
Side Effects Monitoring	Essential to report adverse reactions immediately to healthcare provider

Use cases

Category	Pharmaceuticals > Oncology > Leukemia Treatment Medications
Primary application	Wholesale, distribution, and international sourcing
Brand	Not specified
Product type	Product

Logistics & handling

Lead time	On request
Packaging	As per buyer requirement
Storage condition	As recommended by supplier
Origin	India
Form	As listed by supplier

Commercials (this seller)

Minimum order	1 Bottle
Lead time	On request
Payment terms	As per negotiated commercial agreement.

Buyer questions

Frequently asked by buyers

Common questions B2B buyers ask before sourcing Ponatinib Tablets Ponaxen 15mg. Answers compiled from verified sellers' commercial terms and platform data.

Q: What types of leukemia is Ponatinib Tablets Ponaxen 15mg prescribed for?

A: Ponatinib Tablets Ponaxen 15mg are prescribed specifically for the treatment of chronic myeloid leukemia (CML) and Philadelphia chromosome-positive acute lymphoblastic leukemia (ALL).

Q: How does Ponatinib in Ponaxen 15mg tablets work to treat leukemia?

A: Ponatinib works by inhibiting tyrosine kinase enzymes that are responsible for cancer cell growth and proliferation, thereby blocking the progression of leukemia.

Q: Is Ponaxen 15mg suitable for all leukemia patients?

A: Ponaxen 15mg is intended for patients diagnosed with CML or ALL who require treatment with Ponatinib, typically when resistance or intolerance to prior therapies is observed. Patient suitability must be assessed by a healthcare professional.

Q: What precautions should be taken while using Ponatinib Tablets Ponaxen 15mg?

A: Patients must follow doctor’s instructions closely, monitor for side effects such as cardiovascular events or liver dysfunction, and report any adverse symptoms immediately for optimal safety.

Q: How should Ponaxen 15mg tablets be stored to maintain efficacy?

A: Ponaxen tablets should be stored in a cool, dry place away from direct sunlight and moisture to maintain stability and effectiveness.

Question not answered? Ask sellers directly — typical response within 4 hours.